Nuprobe

Call
Website
85 Bolton St
Cambridge, MA 02140
+1 (857) 242-3907
https://nuprobe.com

NuProbe is a genomics and molecular diagnostics company based in Cambridge, MA, specializing in the development of innovative, high-sensitivity assays for detecting low-frequency mutations and difficult DNA biomarkers. Their proprietary technologies, including Blocker Displacement Amplification (BDA) and Quantitative Amplicon Sequencing (QASeq), enable clinical and research laboratories to enhance the precision of oncology research.

By providing customized assay development and testing services, NuProbe supports all stages of biomarker detection programs across various platforms, including solid tumors and liquid biopsies. Their commitment to accelerating cancer research has positioned them as a leader in the field, driving advancements in the detection and quantification of low-abundant genomic variants.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Mediar Therapeutics, Inc

Strand Therapeutics Inc., based in Boston, MA, is pioneering the development of programmable long-acting mRNA therapeutics aimed at delivering precise, multi-functional treatments for serious diseases, including cancer. By employing advanced genetic circuits, the company's innovative approach allows mRNA to activate therapeutic responses only in diseased cells, thereby enhancing efficacy and minimizing side effects. Co-founded by leading researchers from the MIT Synthetic Biology Center, Strand has created a unique programming language for mRNA that facilitates sophisticated control over protein expression. The company's mission is to transform patient lives through targeted, potentially curative mRNA medicines while exploring strategic partnerships to expand its groundbreaking programs. Generated from the website

Lumicell Inc

Lumicell, based in Newton, MA, is a pioneering company at the forefront of transforming breast cancer surgery through innovative fluorescence imaging technology. Their investigational system is designed to illuminate residual breast cancer in real time, revolutionizing the standard of care in cancer surgery. With a focus on enhancing intraoperative detection of cancerous tissue, Lumicell's technology has the potential to significantly impact the current landscape of breast cancer surgery. Their recent advancements, including pivotal trial results and FDA submissions, highlight their commitment to advancing the field of cancer surgery.Generated from the website

Aprea US, Inc

Aprea Therapeutics is a biopharmaceutical company based in Boston, MA, dedicated to developing innovative targeted cancer therapies that leverage advancements in precision medicine. Their approach focuses on matching treatments to specific cancer-related genetic mutations, aiming to maximize effectiveness while minimizing side effects for patients. The company boasts a robust pipeline of small molecule inhibitors designed to exploit genetic mutations in cancer, thereby widening the therapeutic window and enhancing the destruction of cancer cells while sparing healthy tissue. Aprea is committed to advancing clinical trials and expanding its therapeutic portfolio to provide renewed hope for cancer patients worldwide. Generated from the website
United States›Massachusetts›Cambridge›Nuprobe

Partial Data by Infogroup (c) 2025. All rights reserved.